Potential Link Between Oral Bacterium and Colon Cancer

A recent study published in the journal Nature suggests a potential link between a common type of bacteria associated with dental plaque and a form of colorectal cancer resistant to treatment. The bacterium, Fusobacterium nucleatum, was found in half of the tumors examined, raising significant implications for future treatments and screening methods.

Rising Colorectal Cancer Rates and Younger Patients

Colorectal cancer stands as the second-leading cause of cancer-related deaths in the United States, with projections estimating over 53,000 fatalities in 2024. Alarmingly, rates among younger individuals are sharply increasing, nearly doubling from 11% to 20% of cases between 1995 and 2019. Dr. Flavio Rocha from the Oregon Health & Science University notes the challenge in understanding this shift, emphasizing the importance of early detection.

Study finds patients with certain oral bacterium at higher risk of esophageal cancer

Fusobacterium nucleatum, primarily found in the mouth and linked to oral diseases, was discovered to harbor two distinct subspecies. One of these subspecies acts as a shield for colorectal tumors against cancer-fighting drugs, hindering immune cell response. According to co-lead study author Susan Bullman, individuals with elevated levels of this bacterium in their tumors exhibit poorer responses to chemotherapy and heightened recurrence risks.

Implications for Treatment and Prevention

Dr. Michael White of The University of Texas MD Anderson Cancer Center highlights the potential of targeted therapies, suggesting that clearing these bacteria could enhance treatment response. Clinical trials are forthcoming to investigate the efficacy of antibiotics prior to chemotherapy. Moreover, identifying harmful bacterial subspecies, including Fusobacterium nucleatum, could enable tailored prevention strategies, such as administering antibiotics at the oral stage.

The discovery of this bacterial subtype opens avenues for novel treatments and screening methods. Possibilities include the development of antibiotics targeting specific bacterial strains and utilizing modified bacteria for targeted drug delivery into tumors. Dr. Rocha emphasizes the growing significance of understanding the microbiome’s role in cancer risk, indicating promising prospects for cancer research.

Study Reveals Oral Bacteria’s Role in Accelerating Pancreatic Cancer Development